Bold Legislative Framework Establishes True “$0 Cost-Sharing” Ecosystem for Insulin, Epinephrine, and Inhalers
LANSING, Mich. (June 10, 2026) — This week, Michigan State Sens. Darrin Camilleri (D-Trenton) and Chedrick Greene (D-Saginaw) introduced a sweeping, multi-bill healthcare affordability package aimed at completely eliminating out-of-pocket costs for three of the state’s most high-volume, life-saving medical necessities.
While federal initiatives and other states have historically relied on price caps (such as capping monthly copays at $25 or $35), this landmark legislation establishes an aggressive, first-of-its-kind true zero-dollar cost-sharing ($0 out-of-pocket) framework across private health insurance plans. By eliminating all deductibles, copayments, and coinsurance requirements, the bills ensure that families will no longer face financial barriers at the pharmacy counter for the medicines they need to survive.
“Michigan is drawing a clear line in the sand: if you pay for insurance, you should never be forced to ration your medication just to breathe, manage diabetes, or survive a severe allergic reaction,” said Sen. Camilleri. “These life-saving medications need to be covered.”
Sen. Camilleri is sponsoring Senate Bill 1032, which establishes the nation’s most comprehensive, unrestricted $0 epinephrine mandate. Unlike existing legislation in other states that restricts free epinephrine auto-injectors, like EpiPens, to minors or caps patients at a single twin-pack per year, Sen. Camilleri’s bill provides a universal benefit for every insured resident with no age limits or annual quotas.
“We came to Lansing to represent regular people, and regular people are hurting,” said Sen. Greene. “With these bills, we aren’t just capping prices, we are eliminating them and setting a new national standard for consumer-first healthcare.”
Concurrently, Sen. Greene is sponsoring the remaining two bills in the package to tackle respiratory and diabetic care. Senate Bill 1033 goes further than almost any other state by creating a total $0 diabetes care ecosystem, eliminating cost-sharing not just for insulin, but for the vital diagnostic hardware needed to administer it, including continuous glucose monitors (CGMs), glucometers, lancets, and test strips. Sen. Greene’s second bill, Senate Bill 1034, completely wipes out out-of-pocket costs for prescription inhalers while forgoing insurance rules that stop asthma patients from getting life-saving backup inhalers.
These bills have been referred to the Senate Committee on Health Policy for further consideration.
###